Faculty Documentation

Faculty Information

This information below will be used in our program materials. Please indicate how you would like it to appear including name, degree(s), title(s), and affiliation(s).

First Name

Last Name

Suffix

Degree(s)

Title

Organization

City and State

Title

Organization

City and State

Upload Bio/CV File or Write Your Own?

Upload Bio/CV

Write My Own

Bio/CV Upload

Maximum upload size: 2MB

Bio/CV

Photo/Headshot Upload

Maximum upload size: 2MB

The information below will be used for program planning.

Address

City*

State*

Zip/Postal*

Office Phone

Mobile Phone

Email

Assistant's Name

Assistant's Office Phone

Assistant's Email

Program Information

Project Name or Title

Program Format

Date

Location

*By signing this agreement, I understand that this session may be recorded. I also understand that the content developed for the program may be repurposed and utilized in an Enduring Web Activity with my permission.

Proposed Learning Objectives

After participating in this activity, learners will be better able to:

Understand the current classification system of the lymphoma
Discuss updated data on novel agents and therapeutic approaches for patients with aggressive
lymphoma.
Discuss current standard of care approach in patient with newly diagnosed and relapsed refractory
aggressive B cell lymphoma and T cell lymphoma.
Understand the diagnostic and management approaches in patient with uncommon presentation of
lymphoma and CNS lymphoma.
Understand the disease process and treatment strategies in patients with Hodgkin Lymphoma.
Identify the unmet need and upcoming strategies in elderly patients with lymphoma.
Understand the complex diagnosis paradigm and management of thrombotic microangiopathies

AGREEMENT

Clear

I agree with the terms of this Agreement.

Date

Faculty Guidelines:

Present current and clinically relevant information to meet the stated objectives.
Provide a balanced view of the topic area; be objective when reporting research; and disclose unlabeled use of drugs/products where applicable.
Discuss the safety and adverse effects of drugs/products presented.
Inform myMedEd if you anticipate new applications or changes to the FDA status of a presented product, which may impact the planned content during the course approval period.
Include case studies where applicable.
Support assertions and clinical studies with references where applicable.
Faculty members are responsible for accuracy and completeness of references as well as obtaining permission to reproduce any copyrighted materials. Provide copies of correspondence granting permission.
myMedEd will notify faculty of the program deadline(s). The content requested must be received on or before the deadline date given.